When Desi's swollen ankle began hurting so much that he was unable to run and keep up with his friends, his parents, Jonathan and Susan of Maryland, became concerned. After several doctor visits, a rheumatologist diagnosed Desi with juvenile idiopathic arthritis (JIA), an autoimmune disease. To help manage the symptoms of JIA, Desi receives weekly injections of autoimmune suppressant medicine and daily doses of anti-inflammatory medicines. Jonathan and Susan say that the cost of the medicine has never been an issue, because Desi has been on generics the entire time; they feel lucky that Desi has had access to these medicines.
Desi is now back playing soccer and doing all the normal kids’ stuff. He is just one of millions of patients helped every day by the members of the Association of Accessible Medicines.
Read the 2022 Voices of Access Report
Share Your Voice
As we continue to advocate for accessible generics and biosimilars, we will rely more than ever on the voices of real patients. We invite you to share your story on what generic and biosimilar medicines mean to you and urge you to subscribe for advocacy alerts.
By Erica Klinger, Senior Director, Marketing
Published on January 5, 2023